News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
41,627 Results
Type
Article (2686)
Company Profile (25)
Press Release (38915)
Multimedia
Podcasts (15)
Webinars (2)
Section
Business (15990)
Career Advice (78)
Deals (2143)
Drug Delivery (10)
Drug Development (4184)
Employer Resources (10)
FDA (453)
Job Trends (789)
News (20359)
Policy (1052)
Tag
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Standard (1)
Academia (146)
ADA (4)
Allergies (8)
Alliances (3482)
ALS (9)
Alzheimer's disease (78)
Antibody-drug conjugate (ADC) (60)
Approvals (469)
Artificial intelligence (59)
ASCO (16)
Autoimmune disease (35)
Automation (6)
Bankruptcy (13)
Belgium (1)
Best Places to Work (476)
BIO (12)
Biologics (1)
BIOSECURE Act (2)
Biosimilars (26)
BioSpace Insights (12)
Biotechnology (17)
Bladder cancer (11)
Brain cancer (9)
Breast cancer (64)
Cancer (474)
Cardiovascular disease (17)
Career advice (67)
Career pathing (1)
CAR-T (51)
CDC (2)
CDMO (8)
Cell therapy (115)
Cervical cancer (7)
Clinical research (3653)
Collaboration (279)
Company closure (4)
Compensation (156)
Complete response letters (1)
COVID-19 (186)
CRISPR (13)
C-suite (203)
Cystic fibrosis (8)
Data (665)
Denatured (6)
Depression (12)
Dermatology (1)
Diabetes (25)
Diagnostics (512)
Digital health (2)
Diversity (2)
Diversity, equity & inclusion (1)
Drug discovery (58)
Drug pricing (10)
Duchenne muscular dystrophy (66)
Earnings (4765)
Editorial (6)
Employer branding (1)
Employer resources (8)
Events (6729)
Executive appointments (166)
FDA (671)
Friedreich's ataxia (8)
Frontotemporal dementia (1)
Funding (248)
Gene editing (43)
Generative AI (3)
Gene therapy (83)
GLP-1 (82)
Government (164)
Guidances (25)
Healthcare (727)
Hematology (8)
HIV (3)
Huntington's disease (6)
IgA nephropathy (17)
Immunology and inflammation (45)
Immuno-oncology (20)
Indications (12)
Infectious disease (209)
Inflammatory bowel disease (15)
Inflation Reduction Act (6)
Influenza (9)
Intellectual property (44)
Interviews (7)
IPO (1006)
IRA (7)
Job creations (291)
Job search strategy (62)
JPM (4)
Kidney cancer (13)
Kidney disease (6)
Labor market (12)
Layoffs (55)
Leadership (4)
Legal (213)
Licensing (1)
Liver cancer (6)
Longevity (7)
Lung cancer (44)
Lung diease (3)
Lymphoma (18)
Machine learning (5)
Management (4)
Manufacturing (96)
MASH (19)
Medical device (319)
Medtech (324)
Mergers & acquisitions (1275)
Metabolic disorders (108)
mRNA (16)
Multiple sclerosis (28)
Neurodegenerative disease (46)
Neuropsychiatric disorders (14)
Neuroscience (229)
NextGen: Class of 2026 (354)
Non-profit (159)
Now hiring (17)
Obesity (53)
Opinion (20)
Ovarian cancer (29)
Pain (38)
Pancreatic cancer (28)
Parkinson's disease (17)
Partnered (4)
Patents (76)
Patient recruitment (63)
Patient selection (2)
Peanut (1)
People (6086)
Pharmaceutical (2)
Phase 1 (1565)
Phase 2 (1796)
Phase 3 (972)
Pipeline (900)
Policy (17)
Postmarket research (30)
Preclinical (674)
Press Release (2)
Prostate cancer (9)
Psychedelics (5)
Radiopharmaceuticals (22)
Rare diseases (107)
Real estate (426)
Recruiting (5)
Regulatory (1022)
Reports (7)
Research institute (149)
Resumes & cover letters (9)
Rett syndrome (4)
RNA editing (6)
RSV (3)
Schizophrenia (18)
Series A (62)
Series B (30)
Sickle cell disease (3)
Special edition (3)
Spinal muscular atrophy (3)
Sponsored (1)
Startups (505)
Stomach cancer (3)
Supply chain (6)
Tariffs (2)
The Weekly (9)
Vaccines (75)
Venture capital (23)
Weight loss (29)
Women's health (27)
Worklife (1)
Date
Today (8)
Last 7 days (43)
Last 30 days (207)
Last 365 days (2433)
2026 (1826)
2025 (2437)
2024 (2591)
2023 (2855)
2022 (3751)
2021 (4042)
2020 (3465)
2019 (2060)
2018 (1551)
2017 (1795)
2016 (1620)
2015 (1831)
2014 (1367)
2013 (1186)
2012 (1395)
2011 (1330)
2010 (1175)
Location
Africa (43)
Alabama (3)
Arizona (21)
Asia (2039)
Australia (312)
California (2205)
Canada (340)
China (129)
Colorado (79)
Connecticut (23)
Delaware (16)
Europe (4169)
Florida (80)
Georgia (19)
Hawaii (2)
Idaho (3)
Illinois (33)
India (7)
Indiana (78)
Japan (25)
Kansas (16)
Kentucky (1)
Louisiana (2)
Maryland (79)
Massachusetts (810)
Michigan (15)
Minnesota (33)
Mississippi (1)
Missouri (6)
Nebraska (1)
Nevada (3)
New Hampshire (4)
New Jersey (183)
New York (123)
North Carolina (167)
Northern California (1140)
Ohio (66)
Oklahoma (2)
Oregon (7)
Pennsylvania (154)
Puerto Rico (1)
Rhode Island (4)
South America (40)
South Carolina (2)
Southern California (895)
Tennessee (6)
Texas (213)
United States (4444)
Utah (7)
Virginia (16)
Washington D.C. (4)
Washington State (120)
West Virginia (1)
Wisconsin (21)
41,627 Results for "selecta biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Finance & Accounting for Bioscience West debuts in San Diego this December
Discover innovative financial strategies and expert guidance from leading bioscience finance executives at this first-ever West Coast forum.
September 18, 2026
·
1 min read
Press Releases
Swiss Bioscience and OrganTech sign MOU to explore strategic collaboration in hair regeneration in Europe
Swiss Bioscience selected as OrganTech’s preferred strategic partner in Europe for regulatory development, GMP manufacturing, clinical research, and potential commercialization of the conditioned medium technology.
September 23, 2026
·
1 min read
Mergers & acquisitions
Argenx deepens immuno expertise with $2.2B Forte Biosciences buy
The star of the takeover is Forte Biosciences’ investigational antibody therapy, FB102, which has shown early potential in vitiligo and celiac disease.
July 27, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Slingshot Biosciences Announces Leadership Transition
Dr. Nimisha Srivastava Appointed Chief Executive Officer to Lead the Company into Its Next Chapter
September 25, 2026
·
1 min read
Deals
Selecta Biosciences Announces Merger with Cartesian Therapeutics
Selecta Biosciences, Inc. (NASDAQ: SELB) (the Company) today announced that it has merged with Cartesian Therapeutics, Inc., a clinical-stage biotechnology company pioneering RNA cell therapies for autoimmune diseases.
November 13, 2023
·
15 min read
Press Releases
Ambrosia Biosciences to Participate in Upcoming Investor Conferences
September 16, 2026
·
2 min read
Press Releases
Hummingbird Bioscience Appoints Dr. James Garner as President
September 15, 2026
·
3 min read
Press Releases
Ollin Biosciences Announces Presentations and Symposium at EURETINA 2026
September 24, 2026
·
3 min read
Press Releases
Castle Biosciences to Open New Laboratory Facility in Scottsdale
September 22, 2026
·
4 min read
Press Releases
Genflow Biosciences PLC Announces Half-year Financial Report
September 29, 2026
·
19 min read
1 of 4,163
Next
